Glaxosmithkline Pharmaceuticals Ltd.
GLAXO Share PricePharmaceuticals & Drugs
₹2,510.8
-8.1 (-0.3%)
As on December 4, 2025
Exchange Scrips: BSE500660NSEGLAXOISININE159A01016
Market Cap ₹ 42,366 Cr
P/E Ratio 45.86
Dividend Yield 0.22 %
Performance
Market performance
Open2,520
High2,539
Volumes82,587
Prev2,510.8
Low2,494.9
As on2025-12-04
Historical performance
1 Year High3,515.7
3 Year High3,515.7
5 Year High3,515.7
1 Year Low1,921
3 Year Low1,227
5 Year Low1,227
Fundamentals
Company Valuation
Market Cap (₹Cr)
42,366
Face Value (₹)
10
P/E Ratio
45.86
Dividend Yield
0.22 %
Investment Returns
1 Year
4.5%
3 Years
87.9%
5 Years
61.8%
10 Years
52.9%
Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 2,522.84 | Bearish |
| 10-DMA | 2,508.41 | Bullish |
| 20-DMA | 2,508.89 | Bullish |
| 50-DMA | 2,630.15 | Bearish |
| 100-DMA | 2,760.39 | Bearish |
| 200-DMA | 2,842.18 | Bearish |
Shareholding Pattern
| Field | Sep-2025 | Jun-2025 | Mar-2025 | Dec-2024 | Sep-2024 |
|---|---|---|---|---|---|
| Promoters | 4 | 4 | 4 | 4 | 4 |
| Foreign Investors | 4 | 4 | 4 | 4 | 4 |
| Domestic Investors | --- | --- | --- | --- | --- |
| Public Investors | 122900 | 123625 | 121881 | 119621 | 119224 |
| Government | 2 | 2 | 3 | 3 | 2 |
Financials
Below figures are in Rs. Crores
Balance Sheet
Below figures are in Rs. Crores
Cash Flow
Below figures are in Rs. Crores
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 45.86.
- 3Y Stock Price CAGR of the stock is 23.2.
- The stock has a beta of 0.8.
- In the last financial year, the company had an EBITDA of ₹13233 Million.
- The company generated revenue of ₹37492 Million in the previous financial year.
Glaxosmithkline Pharmaceuticals Ltd.
2510.8-8.1 (-0.3%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1054426.3
No. of Shares: 420 (Approx)
Performance:5.4%
P/L: ₹54426.3
Top Gainers
Peer Comparison
Get Your Portfolio Reviewed
